US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 6.871
- +0.051+0.74%
Close Nov 1 16:00 ET
- 6.871
- 0.0000.00%
Post 20:02 ET
61.02MMarket Cap-114511P/E (TTM)
7.030High6.510Low6.03KVolume7.020Open6.820Pre Close41.07KTurnover0.21%Turnover RatioLossP/E (Static)8.88MShares23.91652wk High-3.73P/B20.03MFloat Cap5.85052wk Low--Dividend TTM2.92MShs Float209.262Historical High--Div YieldTTM7.63%Amplitude5.850Historical Low6.807Avg Price1Lot Size
Serina Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | -826.97%-8.01M | -122.43%-1.58M | -864K | -709K | 7.78%-2.08M | -2.25M |
| Net income from continuing operations | -149.63%-401K | -669.18%-9.44M | --808K | --1.66M | -112.07%-2.68M | ---1.26M |
| Operating gains losses | ---- | ---- | ---291K | ---172K | 159.80%134.79K | ---225.38K |
| Depreciation and amortization | 235.29%57K | 92.31%25K | --17K | --13K | 83.63%61.27K | --33.37K |
| Other non cash items | 759.09%378K | 45.65%67K | --44K | --46K | 221.31%148.26K | ---122.21K |
| Change In working capital | -4,657.14%-4.79M | 151.08%698K | --105K | --278K | 98.42%-11.94K | ---754.79K |
| -Change in receivables | ---- | ---- | ---- | ---- | -99.91%1.11K | --1.27M |
| -Change in prepaid assets | ---2.64M | -5,800.00%-57K | --0 | --1K | 430.63%1.51K | --284 |
| -Change in payables and accrued expense | -1,543.84%-2.11M | 151.40%807K | --146K | --321K | 98.98%-3.89K | ---382.19K |
| -Change in other current liabilities | -34.15%-55K | -18.18%-52K | ---41K | ---44K | -309.64%-164.16K | ---40.08K |
| -Change in other working capital | ---- | ---- | ---- | ---- | 109.55%153.5K | ---1.61M |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | -826.97%-8.01M | -122.43%-1.58M | ---864K | ---709K | 7.78%-2.08M | ---2.25M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | 0 | -14K | -315K | 0 | 19.14%980.94K | 823.32K |
| Net PPE purchase and sale | --0 | ---14K | ---315K | --0 | 91.07%-9.68K | ---108.43K |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | 6.32%990.62K | --931.76K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | --0 | ---14K | ---315K | --0 | 19.14%980.94K | --823.32K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 48,890.91%5.37M | -72.96%2.73M | -11K | 10.09M | 21.80%1.31M | 1.08M |
| Net issuance payments of debt | 3,258.33%379K | -76.34%2.39M | ---12K | --10.09M | 10,231.31%1.31M | ---12.91K |
| Net common stock issuance | ---- | ---- | ---- | ---- | --4.42K | --0 |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | --0 | --90.15K |
| Proceeds from stock option exercised by employees | 498,700.00%4.99M | --4K | --1K | --0 | ---- | ---- |
| Net other financing activities | --0 | --337K | ---- | ---- | ---- | --1M |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 48,890.91%5.37M | -72.96%2.73M | ---11K | --10.09M | 21.80%1.31M | --1.08M |
| Net cash flow | ||||||
| Beginning cash position | -11.66%8.76M | 1,332.14%7.62M | --9.91M | --532K | -52.66%314.85K | --665.06K |
| Current changes in cash | -122.02%-2.64M | -87.88%1.14M | ---1.19M | --9.38M | 162.07%217.38K | ---350.21K |
| End cash Position | -29.90%6.11M | -11.66%8.76M | --8.72M | --9.91M | 69.04%532.23K | --314.85K |
| Free cash flow | -579.30%-8.01M | -124.40%-1.59M | ---1.18M | ---709K | 11.61%-2.09M | ---2.36M |
| Currency Unit | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data